476 related articles for article (PubMed ID: 15538954)
1. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
Andersson PO; Wadenvik H
Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to refractory immune thrombocytopenic purpura.
Bussel JB
Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
[TBL] [Abstract][Full Text] [Related]
3. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
Latifzadeh SZ; Entezari V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
Kuwana M; Kaburaki J; Ikeda Y
J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
[TBL] [Abstract][Full Text] [Related]
6. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
Gernsheimer T
Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet antibodies and their correlation with clinical findings in childhood immune thrombocytopenic purpura.
Yildirmak Y; Yanikkaya-Demirel G; Palanduz A; Kayaalp N
Acta Haematol; 2005; 113(2):109-12. PubMed ID: 15802889
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
McFarland J
Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
10. Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP).
Gaedicke G; Schulze H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):668-70. PubMed ID: 16933247
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
12. Multi-dysfunctional pathophysiology in ITP.
Zhou B; Zhao H; Yang RC; Han ZC
Crit Rev Oncol Hematol; 2005 May; 54(2):107-16. PubMed ID: 15843093
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic implications of T-cell clonopathy of unknown significance in chronic immune thrombocytopenic purpura.
Sabnani I; Tsang P
Platelets; 2009 Mar; 20(2):135-9. PubMed ID: 19235057
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Catani L; Fagioli ME; Tazzari PL; Ricci F; Curti A; Rovito M; Preda P; Chirumbolo G; Amabile M; Lemoli RM; Tura S; Conte R; Baccarani M; Vianelli N
Exp Hematol; 2006 Jul; 34(7):879-87. PubMed ID: 16797415
[TBL] [Abstract][Full Text] [Related]
16. Immune pathophysiology of autoimmune thrombocytopenic purpura.
Semple JW
Blood Rev; 2002 Mar; 16(1):9-12. PubMed ID: 11913985
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
Pogliani EM; Della Volpe A; Casaroli I; Maffe PF; Corneo G
Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
Yang R; Han ZC
Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
[TBL] [Abstract][Full Text] [Related]
19. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
Imbach PA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
